Senior Director, SEC Reporting and Technical Accounting

(Job: 2023-BR-03)

Job Description

Ambrx Biopharma, Inc. (NASDAQ: AMAM) is a clinical-stage biologics company focused on discovering and developing a novel class of specific and selective engineered precision biologics, using our proprietary platform technology that allows site-specific incorporation of synthetic amino acids (SAAs) into proteins within living cells. Our product candidates are designed to overcome the inherent limitations of conventional conjugation approaches that use non-site-specific conjugation, in order to optimize for safety and efficacy benefits across multiple therapeutic classes in broad therapeutic areas.

Ambrx is seeking a highly motivated and dedicated Sr. Director, SEC Reporting and Technical Accounting to be a key member of the Finance team in a fast-paced and dynamic environment. The Sr. Director, SEC Reporting and Technical Accounting will be responsible for the administration and preparation of quarterly and annual financial statements, technical accounting matters and implementation of new accounting standards, equity administration and accounting related areas (such as equity, marketable securities). The Director, SEC Reporting and Technical Accounting reports to the Chief Financial and Operating Officer.

Primary Responsibilities:

Manage external reporting process and preparation of SEC filings including 10-Q, 10-K, 8-K, and 14A, S-3, S-8, etc. for domestic filer requirements. Manage Form 3 and 4 filings, as applicable. Prepare and maintain XBRL tagging and review as part of SEC filings.
Prepare footnote support schedules, tie-out binders for SEC filings and disclosure checklists.
Support earning release process.
Prepare quarterly cash flow statement.
Administer and account for the Company’s equity incentive plans, including options, RSUs, ESPP.
Manage and account for the Company’s marketable securities/investment portfolio.
Support equity/debt transactions, M&A and business development activities, on ad-hoc basis. Support company valuation projects.
Identify complex transactions and emerging accounting standards (SEC, US GAAP, PCAOB, etc.) and research / prepare related technical accounting memos.
Stay abreast of SEC and FASB guidance and pronouncements.
Maintain quarterly/bi-annual SEC reporting schedule and coordinate internal (accounting team) and external (auditor) deliverables related to SEC filings and technical accounting memos.
Collaborate with the legal team to ensure compliance with SEC regulations.
Prepare key monthly reconciliations, including equity roll-forward and stock-based compensation and marketable securities for assigned accounting areas.
Examine contracts to summarize key terms and determine appropriate accounting treatment.
Develop, document, and maintain internal controls related to SEC filings and process and adhere to internal control procedures.
Ensure compliance with Company accounting and internal control policies as well as GAAP.
Implements formal processes for obtaining and analyzing information gathered from internal business units for financial report preparation. Completes ad-hoc financial reporting and analysis, as well as, special projects as needed, other duties as assigned.
Support fundraising / investor relations related efforts on as needed basis

Job Qualifications:

BA/BS degree in accounting or finance.
CPA required.

Minimum of 8 – 10+ years of increasing finance and accounting responsibility, with a mix of public accounting and public company or pre-IPO company experience. Current SEC reporting experience is required.
Excellent technical knowledge of US GAAP and SEC reporting requirements

Experience preparing and reviewing SEC-compliant financial statements.
Previous experience in Biotech industry & public company experience, Big 4 or large regional experience preferred.
Previous experience with equity administration and equity/stock based compensation accounting required. Experience with Certent equity administration system preferred. Experience with American Depository Share programs (non-US entity) is a plus, but not required.
Previous experience with accounting for marketable securities required. Experience with Clearwater software solution preferred.
Experience using Microsoft Dynamics GP (Great Plains) preferred.
Experience with Workiva, Active Disclosure or other SEC reporting solution preferred.
Develops, modifies and executes company policies that affect immediate operations and may also have company-wide effect.
Excellent interpersonal and communication skills, with the ability to approach others in a tactful manner; focus on resolving issues; maintain confidentiality, effectively influence others to effect changes, and present ideas/recommendations clearly and concisely.
Excellent time management, organizational, and project management skills with experience in working toward tight deadlines
Comfortable working in a fast-paced environment and adept at handling change
Ability to effectively facilitate and present in group meetings
Strong analytical, problem-solving, and strategic-thinking skills with a forward-looking focus
Excellent analytical skills, attention to detail, and organization.
Excellent written, verbal and interpersonal communication skill

Pay Scale:

The annualized pay scale for this exempt position is: $200,000 to $235,000, commensurate with experience. We believe this to be possible compensation for this role at the time of this posting, and we may modify this pay scale in the future.

To be considered for this opportunity, please submit your resume/CV referencing the position code to careers@ambrx.com. Applicants whose qualifications and experiences most closely match the requirements will be reviewed. Candidates will only be contacted for evaluative discussions. Ambrx offers competitive compensations & benefits. EOE.